Article

Estimating the global demand curve for a leishmaniasis vaccine: a generalisable approach based on global burden of disease estimates

2021-08-28

Abstract excerpt

<h4>Background</h4> A pressing need exists to develop vaccines for neglected diseases, including leishmaniasis. However, the development of new vaccines is dependent on their value to two key players – vaccine developers and manufacturers who need to have confidence in the global demand in order to commit to research and production; and governments (or other international funders) who need to signal demand based o...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 347f4d66-fc71-5e4b-a800-a2122d3259fe
DOI: 10.1101/2021.08.26.21262379

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Estimating the global demand curve for a leishmaniasis vaccine: a generalisable approach based on global burden of disease estimatesDOI 10.1101/2021.08.26.21262379Read

The potential impact of human visceral leishmaniasis vaccines on population incidenceSemantic proximity Read

Which countries need COVID-19 vaccines the most? Development of a prioritisation toolSemantic proximity Read

Standardized country-level delivery unit cost estimates for routine childhood, routine adolescent, and campaign vaccination: an updated modeling analysisSemantic proximity Read

Economic Burden and Return on Investment of Immunization Programs in Saudi Arabia: A Health Economic EvaluationSemantic proximity Read

Willingness to Pay for a for a Potential Vaccine Against SARS-CoV-2 / COVID-19 Among Adult PersonsSemantic proximity Read

Leveraging mathematical models of disease dynamics and machine learning to improve development of novel malaria interventionsSemantic proximity Read

Are Vaccine Lotteries Worth the Money?Semantic proximity Read

Optimal control of the spatial allocation of COVID-19 vaccines: Italy as a case studySemantic proximity Read

Estimating the Risk of Declining Funding for Malaria in Ghana: The case for continued investment in the malaria responseSemantic proximity Read

Cost of Goods Sold Analysis for Manufacturing mRNA-Based Cell and Gene TherapiesSemantic proximity Read

Efficient and Effective Large-Scale Vaccine DistributionSemantic proximity Read

Advancing Vaccine Access in Tanzania through Community Drug Outlets: A Pre-Implementation Survey on the Acceptability, Appropriateness, and FeasibilitySemantic proximity Read